Yvonne V Louwers
Overview
Explore the profile of Yvonne V Louwers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joham A, Tay C, Laven J, Louwers Y, Azziz R
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39836632
Polycystic ovary syndrome (PCOS) affects 10-13% of women globally. It is a condition with metabolic, reproductive and psychological features, with health impacts across the lifespan. The aetiology of PCOS is...
2.
van der Ham K, Barbagallo F, van Schilfgaarde E, Lujan M, Laven J, Louwers Y
Fertil Steril
. 2024 Sep;
123(2):342-349.
PMID: 39218282
Objective: To study the value of current definitions for follicle number per ovary and ovarian volume in the diagnosis of polycystic ovary syndrome (PCOS). Design: Cross-sectional study. Subjects: Women diagnosed...
3.
van der Ham K, Laven J, Tay C, Mousa A, Teede H, Louwers Y
Fertil Steril
. 2024 Jun;
122(4):727-739.
PMID: 38944177
Importance: As part of the 2023 international evidence-based polycystic ovary syndrome (PCOS) guideline, this meta-analysis investigated the inclusion of Anti-Müllerian hormone (AMH) levels in the diagnostic criteria for PCOS. Objective:...
4.
van der Ham K, Moolhuijsen L, Brewer K, Sisk R, Dunaif A, Laven J, et al.
J Clin Endocrinol Metab
. 2024 May;
109(12):3096-3107.
PMID: 38753423
Context: Hierarchical clustering (HC) identifies subtypes of polycystic ovary syndrome (PCOS). Objective: This work aimed to identify clinically significant subtypes in a PCOS cohort diagnosed with the Rotterdam criteria and...
5.
van der Hoef C, Bawuah Dsane L, Schuur N, Louwers Y, Mens J, Hikary-Bhal N, et al.
Maturitas
. 2024 Apr;
185:108004.
PMID: 38663162
Objectives: This study assessed the uptake of hormone replacement therapy (HRT) in cervical cancer patients with iatrogenic menopause. Survival in relation to HRT use was assessed via a retrospective chart...
6.
van Zwol-Janssens C, Pastoor H, Laven J, Louwers Y, Jiskoot G
Maturitas
. 2024 Apr;
184:107994.
PMID: 38644091
Premature ovarian insufficiency (POI) is a rare condition characterized by loss of ovarian function before the age of 40. POI seems associated with mood disorders and sexual dysfunction. However, there...
7.
van Zwol-Janssens C, Jiskoot G, Schipper J, Louwers Y
Maturitas
. 2024 Mar;
184:107971.
PMID: 38492525
Objective: To establish a set of clinician and patient-reported outcome measures (PROMs) and present the initial findings of a value-based healthcare (VBHC) program in patients with premature ovarian insufficiency (POI)....
8.
Barbagallo F, van der Ham K, Willemsen S, Louwers Y, Laven J
J Clin Endocrinol Metab
. 2024 Mar;
109(10):2561-2570.
PMID: 38486510
Context: Several challenges still exist to adopt the anti-müllerian hormone (AMH) as a marker of polycystic ovary morphology, as included in the recently updated international guideline. Although different evaluations of...
9.
Burns K, Mullin B, Moolhuijsen L, Laisk T, Tyrmi J, Cui J, et al.
BMC Genomics
. 2024 Feb;
25(1):208.
PMID: 38408933
Background: Polycystic ovary syndrome (PCOS) is a complex multifactorial disorder with a substantial genetic component. However, the clinical manifestations of PCOS are heterogeneous with notable differences between lean and obese...
10.
Laven J, Louwers Y
Fertil Steril
. 2024 Feb;
121(5):737-741.
PMID: 38382699
The prediction of menopause and premature ovarian insufficiency (POI) involves understanding the factors that contribute to the timing of these events. Menopause is a natural biological process marked by the...